<DOC>
	<DOCNO>NCT00807846</DOCNO>
	<brief_summary>This Is A Multicenter , Active-Controlled Trial To Evaluate The Effects Of Celecoxib ( Celebrex® ) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis</brief_summary>
	<brief_title>A Study To Evaluate The Effects Of Celecoxib ( Celebrex® ) Or Naproxen On Blood Pressure In Pediatric Subjects</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Polyarticular ( rheumatoid factor positive rheumatoid factor negative ) , oligoarticular extend oligoarticular JIA ≥3 month meet International League Associations Rheumatology ( ILAR ) criterion Juvenile Idiopathic Arthritis ( JIA ) Subjects Systemic JIA active arthritis least 1 joint without active systemic feature eligible ≥2 year age &lt; 18 year age prior Baseline visit Body weight ≥10 kg Baseline visit Candidate chronic NSAID therapy Investigator 's judgment Psoriatic arthritis , enthesitisrelated arthritis , undifferentiated arthritis type JIA Active systemic feature prior 12 week child systemic Juvenile Idiopathic Arthritis ( JIA ) Subjects psoriatic arthritis , enthesitisrelated arthritis , undifferentiated arthritis exclude Subjects active Systemic JIA enrol</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Juvenile Arthritis ; Juvenile Rheumatoid Arthritis ; Blood Pressure ; Juvenile Idiopathic Arthritis</keyword>
</DOC>